ReviewClinical pharmacology and therapeutics2023

Pharmacodynamic Biomarkers Evidentiary Considerations for Biosimilar Development and Approval.

David G Strauss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.